Fintel reports that on June 3, 2025, Wells Fargo upgraded their outlook for Cencora (NYSE:COR) from Equal-Weight to ...

For Cencora, around two-thirds of its overall sales in fiscal 2022 were generated by its top 10 customers. Walgreens and Express Scripts, Cencora's two largest customers, accounted for roughly 27% ...

Cencora assumes no obligation to update any ... including $50 million in February in concurrence with Walgreens Boots Alliance's sale of shares. As we look to the balance of the fiscal year ...

Amazon, CVS Health and Walgreens — are licking their financial wounds after multibillion-dollar investments in primary care ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

and troubles for peer firm Walgreens. Cramer’s previous remarks about Cencora, Inc. (NYSE:COR) have called the firm a “money machine” no matter what the circumstances are. This time around ...

CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

Cherny covers the Healthcare sector, focusing on stocks such as Walgreens Boots Alliance, Hims & Hers Health, and Quest Diagnostics. ;'> Currently, the analyst consensus on Cencora is a Moderate Buy ...

The three dominant wholesalers—Cencora (formerly AmerisourceBergen ... Major retail pharmacy chains such as Walgreens, CVS Pharmacy, Kroger, and Albertsons are significant purchasers of ...